Tate & Lyle to establish new Commercial and Food Innovation Centre in Chicago, Illinois

| Filed in:

Tate & Lyle PLC (“Tate & Lyle”) announces today that it is to establish a new Commercial and Food Innovation Centre in Chicago, Illinois.

In May 2010, Tate & Lyle announced the implementation of a new global organisational structure as part of its clear intention to focus, fix and grow its business. The establishment of this new Centre, bringing Tate & Lyle’s innovation group and speciality food ingredients business in North America together in a new, state-of-the-art facility in Chicago, with enhanced access to customers, represents the next logical step in the development of this new structure.

The new Centre will be the global headquarters of Tate & Lyle’s Innovation and Commercial Development group and the regional headquarters for the Speciality Food Ingredients business in North America. The Centre will also act as the base for those US employees with global responsibilities and, accordingly, the President of the Bulk Ingredients global business unit, and his support staff, will be located there. These groups are all currently located in Decatur, Illinois, and, therefore, employees from these groups in due course will be relocating to Chicago. In total, approximately 160 positions will be located in the new Centre.

The 110,000 square-foot, three-storey building, to be leased by Tate & Lyle and situated in the Hoffman Estates area of Chicago, will feature laboratories, a demonstration kitchen, and sensory testing, analytical and pilot plant facilities. The new Centre will be specifically designed to meet customers’ functional, formulation and nutritional needs and to accelerate the process of bringing new products to market.

The new Centre is expected to be operational by the end of 2011.

Tate & Lyle expects to recognise exceptional costs of up to US$32 million in connection with relocation and restructuring associated with this initiative, and capital expenditure of US$26 million in relation to the fit-out of the new Centre, both to be incurred largely in the year ending 31 March 2012.

Javed Ahmed, Chief Executive of Tate & Lyle said:

“Meeting our customers’ product development and innovation needs is at the very heart of our business. The new Commercial and Food Innovation Centre in Chicago will enable our scientists, marketing, sales and technical experts to collaborate more closely with our customers, and to respond rapidly to their needs for innovative food ingredients and solutions.

“Tate & Lyle’s clear priority is to grow its Speciality Food Ingredients business, supported by cash generated from Bulk Ingredients. This investment represents another important step in positioning Tate & Lyle to deliver on its strategic objectives as we focus, fix and grow our business.”

End

Click here for our press image gallery

About Tate & Lyle PLC:  

Supported by our 165-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients and solutions every day.  

Through our leading expertise in sweetening, mouthfeel and fortification, we develop ingredients and solutions which reduce sugar, calories and fat, add fibre and protein, and provide texture and stability to food and drink in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.  

Tate & Lyle recently acquired CP Kelco, a leading provider of pectin, speciality gums and other nature-based ingredients to create a leader in mouthfeel, significantly enhancing our solutions capabilities. Following this combination, we now have more than 5,000 employees working in around 75 locations in 39 countries, serving customers in more than 120 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives through the Science of Food. By living our purpose, we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.  

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. For the year ended 31 March 2024, and on a pro forma basis which assumes for illustrative purposes that the combination with CP Kelco took place on 1 April 2023, revenue for the enlarged Tate & Lyle Group would have been £2.25 billion. For more information, please visit www.tateandlyle.com or follow Tate & Lyle on LinkedIn, X (Twitter), Facebook or YouTube